ConductScience.org, home

Paper26324116

The march toward malaria vaccines.

Hoffman SL and 3 others. Vaccine, 2015. Cited by 88 papers, by iCite.

Cite this record

ConductScience Library. The march toward malaria vaccines. Papers, record 26324116. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26324116

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The march toward malaria vaccines.
PubMed
Journal
Vaccine
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
88
iCite
Relative citation ratio, by iCite
3.04
iCite
Revised in PubMed
2025-05-29
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hoffman SLStephen L
2Vekemans JJohan
3Richie TLThomas L
4Duffy PEPatrick E

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Malaria VaccinesMajor topic
Malaria, FalciparumMajor topic
Malaria, VivaxMajor topic
Animals
Clinical Trials, Phase III as Topic
Disease Eradication
Humans
Immunity, Cellular
Life Cycle Stages
Plasmodium falciparum
Plasmodium vivax
Recombinant Proteins
Sporozoites

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
Z99 AI999999Intramural NIH HHSUnited StatesZ99AI999999PubMedNIH RePORTER
ZIAAI001007NIHNIH RePORTER
ZIAAI001009NIHNIH RePORTER
ZIAAI001056NIHNIH RePORTER
ZIAAI001170NIHNIH RePORTER

Download CSV of grants

References107

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123136909A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.N Engl J Med2012https://conductscience.org/library/papers/23136909PubMed
215100299Induction in humans of CD8+ and CD4+ T cell and antibody responses by sequential immunization with malaria DNA and recombinant protein.J Immunol2004https://conductscience.org/library/papers/15100299PubMed
315837212Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria.Vaccine2005https://conductscience.org/library/papers/15837212PubMed
423613845The relationship between RTS,S vaccine-induced antibodies, CD4⁺ T cell responses and protection against Plasmodium falciparum infection.PLoS One2013https://conductscience.org/library/papers/23613845PubMed
57685119Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria.Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/7685119PubMed
626245196
Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naïve volunteers: effect of injection volume and dose on infectivity rates.
Malar J2015https://conductscience.org/library/papers/26245196PubMed
725012228A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine.BMC Med2014https://conductscience.org/library/papers/25012228PubMed
824509910Two Plasmodium 6-Cys family-related proteins have distinct and critical roles in liver-stage development.FASEB J2014https://conductscience.org/library/papers/24509910PubMed
99423839Saccharomyces cerevisiae-secreted fusion proteins Pfs25 and Pfs28 elicit potent Plasmodium falciparum transmission-blocking antibodies in mice.Infect Immun1998https://conductscience.org/library/papers/9423839PubMed
1019569965Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection.J Infect Dis2009https://conductscience.org/library/papers/19569965PubMed
1125072396Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites.PLoS Med2014https://conductscience.org/library/papers/25072396PubMed
1217908809Combination of protein and viral vaccines induces potent cellular and humoral immune responses and enhanced protection from murine malaria challenge.Infect Immun2007https://conductscience.org/library/papers/17908809PubMed
1311930326Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites.J Infect Dis2002https://conductscience.org/library/papers/11930326PubMed
1422007715First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.N Engl J Med2011https://conductscience.org/library/papers/22007715PubMed
1511170991Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria.J Infect Dis2001https://conductscience.org/library/papers/11170991PubMed
1618612426Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51.PLoS One2008https://conductscience.org/library/papers/18612426PubMed
1717931153GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives.Expert Rev Vaccines2007https://conductscience.org/library/papers/17931153PubMed
1822496772Modification of Ad5 hexon hypervariable regions circumvents pre-existing Ad5 neutralizing antibodies and induces protective immune responses.PLoS One2012https://conductscience.org/library/papers/22496772PubMed
1921262960The malaria circumsporozoite protein has two functional domains, each with distinct roles as sporozoites journey from mosquito to mammalian host.J Exp Med2011https://conductscience.org/library/papers/21262960PubMed
2018478103Heterologous protein expression is enhanced by harmonizing the codon usage frequencies of the target gene with those of the expression host.PLoS One2008https://conductscience.org/library/papers/18478103PubMed

See all 107 referencesDownload CSV of references

Cited by74

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.

PMIDTitleJournalYearIn PapersSource
41909811Population HLA coverage of experimentally characterized P. falciparum CD8 + T cell epitopes as potential components of a multi-epitope malaria vaccine construct: an in silico insight.Front Bioinform2026https://conductscience.org/library/papers/41909811PubMed
41057897Costs, delivery strategies and implementation challenges for malaria vaccines: a rapid review of literature.Trop Dis Travel Med Vaccines2025https://conductscience.org/library/papers/41057897PubMed
40563989Malaria Vaccines and Global Equity: A Scoping Review of Current Progress and Future Directions.Biomedicines2025https://conductscience.org/library/papers/40563989PubMed
40191019Current Developments in Malaria Vaccination: A Concise Review on Implementation, Challenges, and Future Directions.Clin Pharmacol2025https://conductscience.org/library/papers/40191019PubMed
38702775Statistical design and analysis of controlled human malaria infection trials.Malar J2024https://conductscience.org/library/papers/38702775PubMed
38319556
Protective efficacy and safety of radiation-attenuated and chemo-attenuated Plasmodium Falciparum sporozoite vaccines against controlled and natural malaria infection: a systematic review and meta-analysis of randomized controlled trials.
Infection2024https://conductscience.org/library/papers/38319556PubMed
37525687[Vaccination against malaria].Med Trop Sante Int2023https://conductscience.org/library/papers/37525687PubMed
37198702Malaria vaccines: the 60-year journey of hope and final success-lessons learned and future prospects.Trop Med Health2023https://conductscience.org/library/papers/37198702PubMed
36975676Natural Polymeric Composites Derived from Animals, Plants, and Microbes for Vaccine Delivery and Adjuvant Applications: A Review.Gels2023https://conductscience.org/library/papers/36975676PubMed
36558821Cryopreservation of Plasmodium Sporozoites.Pathogens2022https://conductscience.org/library/papers/36558821PubMed
36333225Non-standard viral genome-derived RNA activates TLR3 and type I IFN signaling to induce cDC1-dependent CD8+ T-cell responses during vaccination in mice.Vaccine2022https://conductscience.org/library/papers/36333225PubMed
35999221A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection.NPJ Vaccines2022https://conductscience.org/library/papers/35999221PubMed
35706028A reverse vaccinology approach on transmembrane carbonic anhydrases from Plasmodium species as vaccine candidates for malaria prevention.Malar J2022https://conductscience.org/library/papers/35706028PubMed
35697668Plasmodium falciparum 7G8 challenge provides conservative prediction of efficacy of PfNF54-based PfSPZ Vaccine in Africa.Nat Commun2022https://conductscience.org/library/papers/35697668PubMed
35672852Systems biology of malaria explored with nonhuman primates.Malar J2022https://conductscience.org/library/papers/35672852PubMed
35488142Plants as Sources of Natural and Recombinant Antimalaria Agents.Mol Biotechnol2022https://conductscience.org/library/papers/35488142PubMed
35357277Current status of experimental models for the study of malaria.Parasitology2022https://conductscience.org/library/papers/35357277PubMed
35060479Transcriptional correlates of malaria in RTS,S/AS01-vaccinated African children: a matched case-control study.Elife2022https://conductscience.org/library/papers/35060479PubMed
34801112Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial.Lancet Infect Dis2022https://conductscience.org/library/papers/34801112PubMed
34696180Plasmodium falciparum Malaria Vaccines and Vaccine Adjuvants.Vaccines (Basel)2021https://conductscience.org/library/papers/34696180PubMed

See all 74 cited byDownload CSV of cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26324116

GET https://conductscience.org/api/papers/v1/26324116/references?page=2